Clifford Chance advised Symrise on acquisition of stake in Synergio
The investment is a step towards expanding its position in product protection in the personal care industry
Clifford Chance advised Symrise on acquisition of stake in Synergio The investment is a step towards expanding its position in product protection in the personal care industry Clifford Chance has advised Symrise AG on the acquisition of a minority stake in Bio-Actives Synergio Ltd. Symrise, through its cosmetic ingredients division, has entered into strategic participation with the...
Clifford Chance advised Symrise on acquisition of stake in Synergio
The investment is a step towards expanding its position in product protection in the personal care industry
Clifford Chance has advised Symrise AG on the acquisition of a minority stake in Bio-Actives Synergio Ltd.
Symrise, through its cosmetic ingredients division, has entered into strategic participation with the biotech company, founded in 2009 in Jerusalem.
Synergio develops plant-based bio-active ingredients for personal care products and cosmetics. Its core technologies include antimicrobial solutions. Using a data-driven biochemistry-based computer platform, Synergio has built up in-depth knowledge of plant bio-actives and their synergies.
Symrise has the option of acquiring a majority stake in Synergio's share capital in the future. The investment is a strategic step towards expanding its position in the area of product protection in the personal care industry.
Its cosmetic ingredients division is a global leader in solutions for the personal care market. Employing over 11,000 people in 2021, Symrise operates in more than 150 countries across the world. Its turnover is around EUR 3.826 million.
The Clifford Chance advisory team comprised partner Christoph Holstein, senior associate Ribana Piontek (corporate/M&A), partner Gunnar Sachs (corporate/healthcare) partner Claudia Milbradt, counsel Florian Reiling and associate Judith Dany (all IP and from Dusseldorf).